Gilead agrees to $247M HIV drug settlement in anti-generic case

Details of a proposed HIV settlement with Gilead are now public, but its fate hinges on a federal judge’s OK next month.

KPH Healthcare Services, a plaintiff in a years-long antitrust case centered around Gilead and access to HIV medicines, filed a proposed order in US District Court for the…
Click here to view original post


ADVERTISEMENT — Advertise With Biotech Networks